ChatGPT told laid-off Amazon engineer to stop taking life-saving drugs and lie to doctors
Bowen Wan’s parents are now suing OpenAI.
Image by Nikolas Kokovlis/NurPhoto/Getty Images
Follow us
- OpenAI faces a lawsuit after Bowen Wan died following ChatGPT's medication tapering advice.
- The complaint says ChatGPT reduced Wan's anti-seizure medication from 400 milligrams to zero without medical supervision.
- The lawsuit alleges ChatGPT encouraged Wan to avoid her doctor and conceal the tapering plan.
- Wan sought help while facing job and immigration pressure after Amazon layoffs.
Key Takeaways by nexos.ai, reviewed by Cybernews staff.
OpenAI is being sued following the death of a 31-year-old Amazon software engineer who took medical advice from ChatGPT.
Bowen Wan, a machine learning and software engineer for Amazon, had suffered from epilepsy for many years but was successfully managing her condition using medication.
However, prior to her death, Wan had consulted ChatGPT for advice on how to taper off the medication that was controlling and reducing epileptic seizures.
ChatGPT had “coached…Wan off the anti-seizure medication (lamotrigine) that kept her alive for years,” the lawsuit reads.
The model designed a day-by-day tapering schedule, reducing her stable 400-milligram dose to 0, something the drug’s own label strictly forbids and specifically says it “should not be abruptly discontinued.”
The drug tapering was not supervised or recommended by a medical professional, just ChatGPT.
While it wasn’t recommended, Wan felt she needed to wean herself off the drugs because she was “losing her words in English” and “needed her English back” for job interviews.
Amazon layoffs sparked dangerous domino effect
Wan, originally from China, was in the process of having her work-based green card approved after years in the backlog.
She then became eligible for US permanent residency if she filed a document through Amazon’s immigration counsel.
However, Wan was made redundant following Amazon’s largest-ever workforce reductions in the company’s history.
Wan was left to find a job before she would have to leave the country at the beginning of 2026.
From there, ChatGPT began tapering her off the medication, citing that certain doses would look better on her immigration medical exam.
The chatbot also encouraged Wan to avoid medical advice and stop seeing her physician, citing “medical freedom over obeying the doctor.”
It also urged Wan to conceal the tapering plan from her physician. When at the doctor's, she declined a blood test.
ChatGPT promised Wan that its plan would help her regain her language skills before the interviews and medical exams, thereby helping her stay in the country, the lawsuit reads.
Wan was a loyal OpenAI patron, paying $200 a month for ChatGPT.
Stay updated with our latest stories and follow us on social media
Be the first to discover new stories, ideas, and updates from our team.
